Tech Company Financing Transactions
Sporos Funding Round
On 5/7/2021, Sporos secured $38.1 million in Series A funding from private investors.
Transaction Overview
Company Name
Announced On
5/7/2021
Transaction Type
Venture Equity
Amount
$38,100,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Houston, TX 77001
USA
Houston, TX 77001
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Sporos is transforming knowledge into new hope for patients with cancer and immune diseases. Harnessing our vast network, strategic resources, and operational expertise, the Sporos team of highly accomplished leaders identifies novel disease mechanisms and catalyzes the development of breakthrough medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Michael Wyzga
Chief Scientific Officer
Jeno Gyuris
Co-Founder
Peter Feinberg
Browse more venture capital transactions:
Prev: 5/7/2021: Aerobiotix venture capital transaction
Next: 5/7/2021: Syxsense venture capital transaction
Share this article
About Database of VC Transactions
We record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs